[CNDSN5] month 5 days (Kang Mei pharmaceutical) the afternoon of May 3rd, the U.S. pharmaceutical andGuangxi Wuzhou Heng Group signed a strategic cooperation agreement in Shenzhen, both as an importantenterprise Chinese pharmaceutical industry, will be the spirit of "the principles and objectives of complementary advantages, mutual benefit, common development, cooperation and win-win", to carry out all-round strategic cooperation in the traditional Chinese medicine raw materials supply chain management and product distribution services and other key areas.

The signing ceremony was held in Shenzhen Kangmei pharmaceutical operations headquarters. Kangmei pharmaceutical chairman, general manager Ma Xingtian and constant group chairman and President Xu Shuqing representing the company signed a strategic cooperation agreement, and conducted in-depth exchanges on specific cooperation.

This strategic cooperation, the U.S. pharmaceutical as currently the largest Chinese medicinal materialssupply services, according to the constant group requirements for security of supply, not higher than themarket price under the premise of one of the main raw material supply chain management services. In order to further promote the sales of products, products of oral medicine and health food market or blank blank channels in the constant group production will be responsible for sales by U.S. pharmaceutical through itsmarketing channels, including the comprehensive coverage of the Internet business platform, drug sales channel terminal. In addition, the U.S. pharmaceutical will also have a constant group of Xueshuantong injection products proxy in some provinces and cities in the gaps in the market; the constant group will be entrusted to the network in the U.S. pharmaceutical pharmacy line wisdom new channel sales products.

The two sides will jointly said, based on medical Internet +, is committed to creating a healthy ecosystemmedicine, the latter will jointly integrate geoherbs resources, hospital pharmacy trusteeship, medical e-commerce, Internet, internet medical and health hospital / medical cloud platform business comprehensive cooperation.

It is understood that, as China's pharmaceutical pharmaceutical industry leading enterprises, and actively implement the strategy of Chinese medicine industry chain investment, established more than 50 covers,planting herbs trading, modern logistics business projects and industrial base in the country, the management of the total trading volume of more than 75% Chinese herbal medicines Trading professional market the depth, established business cooperation with more than 2000 national medical institutions, more than 15 chain pharmacies; the company is also the Chinese medicine industry's first Internet depth layout of the whole industry chain, to build a comprehensive "health + platform + data + services" system "Internet +traditional Chinese medicine" of large enterprises, the future will further improve the network of medical services and medicines block spot trading services, has a unique advantage in the raw material supply chain management and product channel service etc..

The constant group as a focus on the pharmaceutical and health industry innovation and development ofnational high-tech enterprises, to build a new pattern of development of leading industries, health food inChinese manufacturing industry as the core of the new growth industry, supplemented by other business,the company has a production base in the country's largest modern medicine technology, and is located in the forefront of the country the product resources, contained in "China Pharmacopoeia" 99 varieties, 5 varieties of national traditional Chinese medicine protection, have their own original products and the core competitive advantage in many areas of cardiovascular, traumatic, gynecological, health care etc..

The constant group chairman and CEO Xu Shuqing said, the unique advantages in the constant group andU.S. pharmaceutical medicines in the management of resources and market channels has a strong strategicfit, a huge space for cooperation.

The signing of the U.S. pharmaceutical and constant group strategic cooperation agreement, will be theexample of China's pharmaceutical industry, a complementary, win-win cooperation, both are of great significance for both the business and the development of the industry. 3

Editor: small Shen